Iridex (IRIX) Current Deferred Tax Assets (2015)

Name: Iridex (IRIX) Current Deferred Tax Assets (2015) | Business Quant
Creator: Business Quant

Iridex's quarterly Current Deferred Tax Assets came in at $1.6 million in Q4 2015, little changed quarter-over-quarter from $1.6 million in Q3 2015.

Iridex has reported Current Deferred Tax Assets for 1 years, with the latest figure at $1.6 million in Q4 2015.

For the quarter ending Q4 2015, Current Deferred Tax Assets changed N/A year-over-year to $1.6 million; the trailing twelve-month figure through Oct 2015 stood at $1.6 million (changed N/A YoY), and the FY2015 full-year result was $1.6 million, changed N/A from the prior year.
Current Deferred Tax Assets for Q4 2015 stood at $1.6 million, roughly flat from $1.6 million in the prior quarter.
The five-year high for Current Deferred Tax Assets was $1.6 million in Q1 2015, with the low at $1.6 million in Q1 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn
10	Iridex	18.87 Mn	14.27 Mn	4.74 Mn

Download Data 🔒